Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CVP-Guided Hydration for CIN Prevention in CHF and CKD
NCT02405377Completed
- Sponsor
- Chinese PLA General Hospital
- Start
- Feb 2014
- Primary completion
- Feb 2015
- Countries
- 1
01
Overview
Randomised, double-blind trial of sodium chloride in contrast-induced nephropathy (CIN) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Incidence of Contrast Induced Nephropathy at 7 days. Started Feb 2014; status: completed.
02
Drugs
sodium chloride
03
Conditions
contrast-induced nephropathy (CIN)
Beyond the preview
Go deeper on NCT02405377.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02405377.